Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Prognostic factors in uveitis

Poster Details

First Author: N.Albaroudi MOROCCO

Co Author(s):    M. Tijani   N. Boutimzine   O. Cherkaoui   M. Laghmari           

Abstract Details

Purpose:

To evaluate prognostic factors of vision loss among patients with uveitis.

Setting:

Mohammed V University, Ibn Sina University Hospital (H�Ã�´pital des sp�Ã�©cialit�Ã�©s), Ophthalmology Department 'A', Rabat, Morocco.

Methods:

This descriptive and retrospective study included all patients diagnosed with uveitis who attended the uveitis consultation at the teaching hospital of Rabat, Morocco, during 5 years. Information regarding demographic data, uveitis type, bilaterality of the disease, etiology and complications were gathered from patients records. The statistical analysis was performed using Khi-2, Wilcoxon, Kruskall-Wallis tests and binary logistic regression.

Results:

139 eyes of 89 patients were included: 60.7% men and 39.3% women. The mean age (years) was 31.1 �Â�± 16.8. Panuveitis (85.4%) and posterior uveitis (72.7%) were responsible of final visual acuity (VA) equal or less than 1/10 (p < 0.001). Cataract, posterior synechiae, vitreous opacities, epimacular membrane (ERM) and cystoid macular edema (CME) were the most frequent complications. Using multivariate logistic regression, the prognostic factors associated with severe vision loss (VA equal or less than 1/10) were the type of uveitis (posterior and panuveitis), CME, ERM, macular scarring and optic atrophy (p < 0.05).

Conclusions:

Although this study included a limited number of subjects, the results showed that final VA was equal or less than 1/10 in 59% of eyes diagnosed with uveitis and was associated with risk factors including posterior segment involvement (panuveitis and posterior uveitis), CME and ERM.

Financial Disclosure:

NONE

Back to Poster listing